Follow CGSP on Social Media

Listen to the CGSP Podcast

Seychelles Doubles Down on Chinese Vaccines Amid Rising Infection Rates and Efficacy Concerns

A new batch of Sinopharm jabs landed in the Seychelles on Tuesday, highlighting the government’s loyalty to the Chinese jab, even amid resurgent infection rates in the Indian Ocean island country.

The Seychelles, more than almost any other country, took an early gamble by relying primarily on Chinese vaccines, specifically those from Sinopharm that now account for 57% of all vaccines in the country.

Lead the Conversation on China

Subscribe Today to Get Full Access to The China-Global South Project

Check Out Everything You'll Get With Your Subscription

The China-Global South Daily Brief delivered to your inbox at 6AM Washington time

Full access to exclusive news and analysis from editors based in the Global South

Transcripts of CGSP’s twice-weekly podcasts

Students and teachers with a valid .edu email address are eligible for a 50% discount off monthly or yearly subscriptions. Email us to receive a discount code.

What is The China-Global South Project?


The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.